Ambu A/S/DKr AMBU B
08:00
10:00
12:00
13:55
15:55
1D1W1MYTD1Y5YMAX
About Ambu A/S
Ambu A/S is a Danish company operating in the medical device industry, focusing on the development and marketing of products for hospitals and healthcare providers. The company specializes in anesthesiology, patient monitoring and diagnostics, and emergency care solutions. Some of Ambu's key products include single-use endoscopes, resuscitators, and electrodes for patient monitoring. Founded in 1937, Ambu is headquartered in Ballerup, Denmark, and serves a global market with a significant presence in Europe, North America, and Asia. The company is known for its strategic emphasis on innovation in single-use devices, which helps reduce the risk of cross-contamination and improves healthcare efficiency.
Ticker
DKr AMBU B
Sector
Primary listing
CSE
Employees
5,200
Headquarters
Ballerup, Denmark
Website
Ambu A/S Metrics
BasicAdvanced
kr 19B
35.27
kr 2.04
1.45
kr 0.41
0.57%
Price and volume
Market cap
kr 19B
Beta
1.45
52-week high
kr 122.30
52-week low
kr 70.80
Average daily volume
800K
Dividend rate
kr 0.41
Financial strength
Current ratio
2.86
Quick ratio
1.568
Long term debt to equity
7.836
Total debt to equity
9.228
Dividend payout ratio (TTM)
20.40%
Interest coverage (TTM)
20.14%
Profitability
EBITDA (TTM)
858
Gross margin (TTM)
60.07%
Net profit margin (TTM)
8.94%
Operating margin (TTM)
11.59%
Effective tax rate (TTM)
18.93%
Revenue per employee (TTM)
kr 1,170,000
Management effectiveness
Return on assets (TTM)
5.89%
Return on equity (TTM)
9.20%
Valuation
Price to earnings (TTM)
35.274
Price to revenue (TTM)
3.146
Price to book
3.19
Price to tangible book (TTM)
6.94
Price to free cash flow (TTM)
54.538
Free cash flow yield (TTM)
1.83%
Free cash flow per share (TTM)
1.318
Dividend yield (TTM)
0.57%
Forward dividend yield
0.57%
Growth
Revenue change (TTM)
7.76%
Earnings per share change (TTM)
67.89%
3-year revenue growth (CAGR)
10.22%
10-year revenue growth (CAGR)
11.98%
3-year earnings per share growth (CAGR)
75.65%
10-year earnings per share growth (CAGR)
11.32%
10-year dividend per share growth (CAGR)
7.99%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ambu A/S stock?
Ambu A/S (AMBU B) has a market cap of DKr19B as of March 17, 2026.
What is the P/E ratio for Ambu A/S stock?
The price to earnings (P/E) ratio for Ambu A/S (AMBU B) stock is 35.27 as of March 17, 2026.
Does Ambu A/S stock pay dividends?
Yes, the Ambu A/S (AMBU B) stock pays dividends to shareholders. As of March 17, 2026, the dividend rate is DKr0.41 and the yield is 0.57%. Ambu A/S has a payout ratio of 20.4% on a trailing twelve-month basis.
When is the next Ambu A/S dividend payment date?
The next Ambu A/S (AMBU B) dividend payment date is unconfirmed.
What is the beta indicator for Ambu A/S?
Ambu A/S (AMBU B) has a beta rating of 1.45. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.